Actuate-linked trial of 9-ING-41 plus carboplatin in salivary gland cancer posts resultsTrial updateActuate Therapeutics Inc.pemetrexed
Actuate registers Phase 1/2 trial of oral elraglusib in advanced solid tumorsTrial updateActuate Therapeutics Inc.elraglusib
Sign inSign in